(Q59300523)
Statements
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study (English)
D Amadori
M Marangolo
P Pacini
A Ravaioli
A Rossi
A Gambi
G Catalano
D Perroni
E Scarpi
D C Giunchi
A Tienghi
A Becciolini
1 September 2000